Characterization of Alpha 1 D-adrenoceptor Subtype in Rat Myocardium, Aorta and Other Tissues

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1996 Sep 1

PMID 8886408

Citations 12

Authors

X F Deng

S Chemtob

D R Varma

Affiliations

Soon will be listed here.

Abstract

1. This study was done to characterize the functional role of alpha 1D-adrenoceptors in rat myocardium, aorta, spleen, vas deferens and prostate by use of the selective antagonist BMY 7378. 2. BMY 7378 inhibited [3H]-prazosin binding to aortic membranes with a potency (pKi 9.8 +/- 0.40) approximately 100 fold higher than in right ventricular membranes (pKi 7.47 +/- 0.11) and approximately 1,000 fold higher than that in plasma membranes of the prostate (pKi 6.62 +/- 0.39), vas deferens (pKi 6.67 +/- 0.15), salivary gland (pKi 6.46 +/- 0.38) and liver (6.58 +/- 0.06). 3. BMY 7378 antagonized the positive inotropic effects of phenylephrine (in the presence of 1 microM propranolol) on right ventricles (pA2 7.0 +/- 0.11), left atria (pKB 7.04 +/- 0.18) and papillary muscles (pKB 6.9 +/- 0.1) and inhibited phenylephrine-induced increase in inositol phosphates. 4. BMY 7378 was approximately 100 fold more potent as an antagonist of phenylephrine on aortic strips (pA2 9.0 +/- 0.13) than on vas deferens (pKB 7.17 +/- 0.08) and spleen (pKB 7.16 +/- 0.21); it was ineffective on the prostate. 5. Chloroethylclonidine suppressed the maximal effects of phenylephrine on spleen; 5-methylurapidil antagonized the effects of phenylephrine on aortic strips (pA2 7.98 +/- 0.08), vas deferens (pKB 8.89 +/- 0.07) and prostate (pKB 8.85 +/- 0.21). 6. BMY 7378 caused a dose (0.1-100 nmol kg-1)-dependent decrease in mean blood pressure of urethane-anaesthetized rats and its hypotensive efficacy was equal to that of hexamethonium. 7. The data suggest that alpha 1D-adrenoceptors play a significant role in rat aorta, a minor role in the heart, vas deferens and spleen and virtually no role in the prostate.

Citing Articles

Role of sympathetic pathway in light-phase time-restricted feeding-induced blood pressure circadian rhythm alteration.

Hou T, Chacon A, Su W, Katsumata Y, Guo Z, Gong M Front Nutr. 2022; 9:969345.

PMID: 36159491 PMC: 9493072. DOI: 10.3389/fnut.2022.969345.

Altered expression profile of renal α(1D)-adrenergic receptor in diabetes and its modulation by PPAR agonists.

Zhao X, Zhang Y, Leander M, Li L, Wang G, Emmett N J Diabetes Res. 2014; 2014:725634.

PMID: 24772448 PMC: 3977090. DOI: 10.1155/2014/725634.

alpha-Adrenoceptor-mediated depletion of phosphatidylinositol 4, 5-bisphosphate inhibits activation of volume-regulated anion channels in mouse ventricular myocytes.

Ichishima K, Yamamoto S, Iwamoto T, Ehara T Br J Pharmacol. 2010; 161(1):193-206.

PMID: 20718750 PMC: 2962827. DOI: 10.1111/j.1476-5381.2010.00896.x.

Inhibitory effect of fentanyl on phenylephrine-induced contraction of the rat aorta.

Park K, Sohn J, Jeong Y, Sung H, Shin I, Lee H Yonsei Med J. 2009; 50(3):414-21.

PMID: 19568605 PMC: 2703766. DOI: 10.3349/ymj.2009.50.3.414.

Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances alpha1D-adrenergic receptor constriction.

Cohn H, Harris D, Pesant S, Pfeiffer M, Zhou R, Koch W Am J Physiol Heart Circ Physiol. 2008; 295(4):H1695-704.

PMID: 18723764 PMC: 2593515. DOI: 10.1152/ajpheart.00564.2008.

References

Besse J, FURCHGOTT R . Dissociation constants and relative efficacies of agonists acting on alpha adrenergic receptors in rabbit aorta. J Pharmacol Exp Ther. 1976; 197(1):66-78. View

ARUNLAKSHANA O, SCHILD H . Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959; 14(1):48-58. PMC: 1481829. DOI: 10.1111/j.1476-5381.1959.tb00928.x. View

Morrow A, Creese I . Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Mol Pharmacol. 1986; 29(4):321-30. View

Yocca F, Hyslop D, Smith D, Maayani S . BMY 7378, a buspirone analog with high affinity, selectivity and low intrinsic activity at the 5-HT1A receptor in rat and guinea pig hippocampal membranes. Eur J Pharmacol. 1987; 137(2-3):293-4. DOI: 10.1016/0014-2999(87)90241-x. View

Han C, Abel P, Minneman K . Heterogeneity of alpha 1-adrenergic receptors revealed by chlorethylclonidine. Mol Pharmacol. 1987; 32(4):505-10. View

Jagadeesh G, Deth R . Different affinity states of alpha-1 adrenergic receptors defined by agonists and antagonists in bovine aorta plasma membranes. J Pharmacol Exp Ther. 1987; 243(2):430-6. View

Minneman K, Han C, Abel P . Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101. Mol Pharmacol. 1988; 33(5):509-14. View

Michel A, Loury D, Whiting R . Identification of a single alpha 1-adrenoceptor corresponding to the alpha 1A-subtype in rat submaxillary gland. Br J Pharmacol. 1989; 98(3):883-9. PMC: 1854785. DOI: 10.1111/j.1476-5381.1989.tb14617.x. View

Perez D, Piascik M, Graham R . Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA. Mol Pharmacol. 1991; 40(6):876-83. View

10.

Aboud R, Shafii M, Docherty J . Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. Br J Pharmacol. 1993; 109(1):80-7. PMC: 2175602. DOI: 10.1111/j.1476-5381.1993.tb13534.x. View

11.

Terzic A, Puceat M, Vassort G, Vogel S . Cardiac alpha 1-adrenoceptors: an overview. Pharmacol Rev. 1993; 45(2):147-75. View

12.

Yazawa H, Honda K . Alpha 1-adrenoceptor subtype in the rat prostate is preferentially the alpha 1A type. Jpn J Pharmacol. 1993; 62(3):297-304. DOI: 10.1254/jjp.62.297. View

13.

Forray C, BARD J, Wetzel J, Chiu G, Shapiro E, Tang R . The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype. Mol Pharmacol. 1994; 45(4):703-8. View

14.

Rokosh D, Bailey B, Stewart A, Karns L, Long C, Simpson P . Distribution of alpha 1C-adrenergic receptor mRNA in adult rat tissues by RNase protection assay and comparison with alpha 1B and alpha 1D. Biochem Biophys Res Commun. 1994; 200(3):1177-84. DOI: 10.1006/bbrc.1994.1575. View

15.

Michel M, Hanft G, Gross G . Radioligand binding studies of alpha 1-adrenoceptor subtypes in rat heart. Br J Pharmacol. 1994; 111(2):533-8. PMC: 1909949. DOI: 10.1111/j.1476-5381.1994.tb14770.x. View

16.

Michel M, Hanft G, Gross G . Functional studies on alpha 1-adrenoceptor subtypes mediating inotropic effects in rat right ventricle. Br J Pharmacol. 1994; 111(2):539-46. PMC: 1909968. DOI: 10.1111/j.1476-5381.1994.tb14771.x. View

17.

Price D, Chari R, Berkowitz D, Meyers W, Schwinn D . Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification. Mol Pharmacol. 1994; 46(2):221-6. View

18.

Stewart A, Rokosh D, Bailey B, Karns L, Chang K, Long C . Cloning of the rat alpha 1C-adrenergic receptor from cardiac myocytes. alpha 1C, alpha 1B, and alpha 1D mRNAs are present in cardiac myocytes but not in cardiac fibroblasts. Circ Res. 1994; 75(4):796-802. DOI: 10.1161/01.res.75.4.796. View

19.

Laz T, Forray C, Smith K, BARD J, Vaysse P, Branchek T . The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype. Mol Pharmacol. 1994; 46(3):414-22. View

20.

Faure C, Pimoule C, Arbilla S, Langer S, Graham D . Expression of alpha 1-adrenoceptor subtypes in rat tissues: implications for alpha 1-adrenoceptor classification. Eur J Pharmacol. 1994; 268(2):141-9. DOI: 10.1016/0922-4106(94)90183-x. View